Analysts anticipate Treace Medical Concepts to report an earnings per share (EPS) of $-0.27.
Investors in Treace Medical Concepts are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Overview of Past Earnings
During the last quarter, the company reported an EPS missed by $0.05, leading to a 2.4% drop in the share price on the subsequent day.
Here's a look at Treace Medical Concepts's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
-0.29
-0.3
-0.09
-0.26
EPS Actual
-0.34
-0.3
-0.10
-0.28
Price Change %
-2.0%
-62.0%
-6.0%
-38.0%
Performance of Treace Medical Concepts Shares
Shares of Treace Medical Concepts were trading at $4.78 as of November 01. Over the last 52-week period, shares are down 50.9%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analyst Insights on Treace Medical Concepts
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Treace Medical Concepts.
With 3 analyst ratings, Treace Medical Concepts has a consensus rating of Neutral. The average one-year price target is ...